Company intelligence / Profile preview

Femasys Inc.

Suwanee, Georgia, United Statesfemasys.com ↗

Ownership: Public · FEMY
Employees: ~26
Development stage: Commercial

Overview

Femasys has four approved products ready for sale in the US, Europe, and Canada. Its FDA-cleared FemaSeed® Intratubal Insemination offers a cost-effective alternative to IVF. FemBloc®, its non-surgical permanent birth control solution, is in late-stage clinical development. The company also markets diagnostic tools for fallopian tube assessment and cervical cancer diagnosis. Clinical results indicate safety and effectiveness with regulatory clearances achieved in multiple regions.

Therapeutic areas: Women's HealthOncology
Modalities: Medical devices (minimally invasive, office-based)Diagnostic devicesTherapeutic devices for reproductive health and contraception
Industry: Therapeutic Medical Devices

Drug pipeline

4 assets

FemBloc

Phase 3

Indications: Permanent birth control

3 more assets in the full pipeline.

Financials

Market cap: $11M
Total revenue: $2.3M
Enterprise value: $14.3M

Beyond the preview

Go deeper on Femasys Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Femasys Inc..